Provider Profile:
Khalil Choucair, M.D., MSc

School

• American University of Beirut

Residency

• University of Kansas School of Medicine

Fellowships

• Wayne State University School of Medicine

Awards

• Distinguished Service Chief Fellow Award
• SITC Clinical Immuno-Oncology Network (SCION) Scholar
• W.C (Carter) Goodpasture Resident Performance Award
• Young Achiever Award- ACP
• John McCrae Fellowship Award/McGill University
• "Tres Bien" Honorary Mention of the French Baccalaureate(

Professional Memberships

• American Society of Clinical Oncology (ASCO)
• Society of Immunotherapy of Cancer
• International Association for the Study of Lung Cancer
• American Association for Cancer Research
• Michigan Society of Hematology and Oncology
• American College of Physicians

• Khalil Choucair, Andrew Elliott, Matthew James Oberley, Phillip Walker, April K Salama, Azhar Saeed,Hirva Mamdani, Dipesh Uprety, Wafik S El-Deiry, Himisha Beltran, Stephen V Liu, Chul Kim, AbdulRafeh Naqash, Emil Lou, Lujia Chen, Anwaar Saeed - Molecular and immune landscape of tumors ingeriatric patients with non-small cell lung cancer, melanoma, and renal cell carcinoma: BMJ Oncology.2025; 4 (1). https://doi.org/10.1136/bmjonc-2024-000551
• Abdul Rafeh Naqash, Charalampos S.Floudas, Etan Aber, Asaf Maoz, Amin H. Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca,Chul Kim, Julia Judd, Luis E. Raez, Gilberto Lopes, Jorge J. Nieva, Hossein Borghaei, Naoko Takebe,Patrick C. Ma, Balazs Halmos, David J. Kwiatkowski, Stephen V. Liu, Hirva Mamdani. Influence of TP-53co-mutation on the tumor immune microenvironment and clinical outcomes with immune checkpointinhibitors in STK11 mutant non-small cell lung cancer. JCO Precision Oncology. 2024; 8 (8).
• Khalil Choucair, Caroline Nebhan, Alessio Cortellini, Stijn Hentzen, Yinghong Wang, Cynthia Liu, RaffaeleGiusti, Marco Filetti, Paolo Antonio Ascierto, Vito Vanella, and et al. 2023. Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) asBiomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune CheckpointInhibitors: Impact on Efficacy and Survival. Cancers. 2023; 15(20)
• Khalil Choucair, Bassam IbrahimMattar, Quoc Van Truong, Travis Lee Koeneke, Phu Van Truong, Christopher Dakhil, Michael W. Cannonet al. Liquid Biopsy-based, biomarker-driven Precision Therapy in Patients with Advanced SolidTumors: a Real-World Experience from a Community-based Oncology Practice. The Oncologist. 2022;27(3)
• Khalil Choucair, Susan Morand, Laura Stanbery, Gerald Edelman, Lance Dworkin, JohnNemunaitis. TMB: A Promising Immune-response Biomarker, and Potential Spearhead in AdvancingTargeted Therapy Trials. Nature/Cancer Gene Therapy. 2020; 27.